The inaugural class of the IMPACT-AD program, which is co-directed by a USC professor, will educate 35 professionals at various career stages on conducting more diverse clinical trials.
USC’s Center for Advancing Sociodemographic and Economic Study of Alzheimer’s Disease will explore the enormous costs of Alzheimer’s and related dementias.
Death certificate data appear to underestimate the true mortality burden of dementia, Alzheimer’s disease and other cognitive impairment, according to a USC-led study.
“It’s never too early or too late to take action,” says Lon Schneider of the Keck School of Medicine of USC, co-director of the USC Alzheimer Disease Research Center’s clinical core.
USC research shows how several major countries could prepare their health systems to ensure patients can get Alzheimer’s treatments once they hit the market.
Although scientists have long known APOE4 is a leading risk factor for Alzheimer’s disease, they were unsure how exactly it drives a decline in memory. USC researchers now believe they have an answer.
In a first, a USC study has shown that drugs already being used for blood pressure and cholesterol control could provide benefits for Alzheimer’s and other dementias.
Keck School of Medicine of USC is launching a large clinical trial that targets amyloid plaques in the brain. The goal: to see whether a drug can clear or slow this plaque in people who have early Alzheimer’s or who appear clinically normal.
María Aranda will bring her expertise as a researcher and a social worker to Gov. Gavin Newsom’s Task Force on Alzheimer’s Prevention and Preparedness.
Funding from the National Institutes of Health — the world’s largest public funder of biomedical research — was $68 million last year, a substantial increase from $13 million in 2015.
November is Alzheimer’s Awareness Month, and USC scientists are researching healthy lifestyle choices and certain drugs that might reduce the risk of developing the disease.
Women in their 70s and 80s who were exposed to fine particle pollution had declines in memory and physical brain changes that were not seen in women who breathed cleaner air.
Christian Pike of the USC Leonard Davis School of Gerontology and USC health policy expert Julie Zissimopoulos as they discuss the latest research into the disease.
As Alzheimer’s Awareness Month begins, USC researchers examine how the disease affects men and women, including theories on estrogen depletion and higher life expectancy.
USC and Duke researchers propose the Alzheimer’s Disease Exposome to address gaps in understanding how environmental factors interact with genetics to increase or reduce risk for the disease.
USC Leonard Davis Professor Mara Mather, co-author of a new study on the locus coeruleus, explains its role in the onset of Alzheimer’s disease and cognitive decline.
A new USC study has found that most older Americans do not meet with a dementia specialist and the use of dementia specialty care is particularly low for Hispanics and Asians.
Amid mounting discoveries about Alzheimer’s complex list of triggers, USC Dornsife researchers turn their attention to preventive measures.
USC research into Alzheimer’s — which will be on display at the upcoming Alzheimer’s Association International Conference — has uncovered much about the disease, including establishing a link between cardiovascular health and a fully functioning brain.
The cells — known as pericytes — preserve neurons in the brain, which can keep dementia and other cognitive disorders at bay.
New research from a USC professor reinforces the value of designing to maximize natural light, especially for aging adults with a variety of health issues.
The USC Dornsife research underscores the importance of detecting diabetes and other metabolic diseases in adults as early as possible.
The findings — focused on components contained in green tea and carrots — lend credence to the idea that certain readily available, plant-based supplements might offer protection against dementia in people.
Brain changes associated with leaky capillaries suggest new, potential drug targets as well as a way to diagnose the disease sooner.